• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间变性甲状腺癌:WHO 分类、临床病理特征和分期的更新。

Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.

机构信息

Cancer Molecular Pathology, School of Medicine and Destistry, Gold Coast campus, Griffith University, gold Coast, Australia.

Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.

出版信息

Histol Histopathol. 2021 Mar;36(3):239-248. doi: 10.14670/HH-18-277. Epub 2020 Nov 10.

DOI:10.14670/HH-18-277
PMID:33170501
Abstract

Anaplastic thyroid carcinoma is an uncommon carcinoma representing 1 to 4% of all thyroid cancers. The carcinoma is most common in females of the eight decades. It is a locally advanced cancer with frequent infiltration of surrounding organs, blood vessels and skin of neck. Paraneoplastic manifestations could occur. Approximately half of the patients with anaplastic thyroid carcinoma had distant metastasis with lung and brain as the most frequent sites of metastasis. The median survival of patients with anaplastic thyroid carcinoma reported was from 1 to 6 months. The terminology of the cancer in World Health Organization is "anaplastic thyroid carcinoma" rather than "undifferentiated thyroid carcinoma". In the latest American Joint Committee on Cancer (AJCC) TNM staging system for anaplastic thyroid carcinoma, there are updates on T and N categories. To conclude, updated knowledge of clinicopathological features, classification, pathological staging will improve our understanding of the cancer and will help in the management of the patients with this aggressive cancer.

摘要

间变性甲状腺癌是一种罕见的癌,占所有甲状腺癌的 1%至 4%。该癌在八九十岁的女性中最为常见。它是一种局部晚期癌症,常浸润周围器官、血管和颈部皮肤。可能会出现副肿瘤表现。大约一半的间变性甲状腺癌患者有远处转移,肺和脑是最常见的转移部位。报道的间变性甲状腺癌患者的中位生存时间为 1 至 6 个月。世界卫生组织对这种癌症的命名为“间变性甲状腺癌”,而非“未分化甲状腺癌”。在最新的美国癌症联合委员会(AJCC)间变性甲状腺癌 TNM 分期系统中,T 分期和 N 分期都有更新。总之,对临床病理特征、分类和病理分期的最新认识将提高我们对这种癌症的认识,并有助于管理这种侵袭性癌症的患者。

相似文献

1
Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.间变性甲状腺癌:WHO 分类、临床病理特征和分期的更新。
Histol Histopathol. 2021 Mar;36(3):239-248. doi: 10.14670/HH-18-277. Epub 2020 Nov 10.
2
A relook at the 8th edition of the AJCC TNM staging system of anaplastic thyroid carcinoma: A SEER-based study.重新审视第 8 版 AJCC TNM 分期系统在间变性甲状腺癌中的应用:一项基于 SEER 的研究。
Clin Endocrinol (Oxf). 2021 Apr;94(4):700-710. doi: 10.1111/cen.14371. Epub 2020 Dec 26.
3
Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.间变性甲状腺癌的积极姑息治疗与生存情况
JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1128-32. doi: 10.1001/jamaoto.2015.2332.
4
Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.分化型和间变性甲状腺癌:美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2018 Jan;68(1):55-63. doi: 10.3322/caac.21439. Epub 2017 Nov 1.
5
Anaplastic thyroid carcinoma.间变性甲状腺癌。
Semin Diagn Pathol. 2020 Sep;37(5):248-256. doi: 10.1053/j.semdp.2020.06.005. Epub 2020 Jun 24.
6
[Interpretation of the pathological diagnostic criteria and characteristics of high-grade thyroid follicular-derived carcinoma in the 5 edition WHO classification].[《世界卫生组织(WHO)第5版分类中高级别甲状腺滤泡源性癌的病理诊断标准及特征解读》]
Zhonghua Yi Xue Za Zhi. 2024 May 14;104(18):1578-1583. doi: 10.3760/cma.j.cn112137-20230902-00374.
7
Anaplastic Thyroid Carcinoma.未分化甲状腺癌
Mayo Clin Proc. 2021 Jul;96(7):2008-2011. doi: 10.1016/j.mayocp.2021.05.023.
8
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?美国癌症联合委员会/肿瘤-淋巴结-转移分期系统(第八版)对分化型和间变性甲状腺癌的更新:有哪些变化及原因?
Thyroid. 2017 Jun;27(6):751-756. doi: 10.1089/thy.2017.0102. Epub 2017 May 19.
9
New Perspectives Regarding Anaplastic Thyroid Carcinoma Approach Improvement.关于间变性甲状腺癌治疗方法改进的新观点。
Endocr Metab Immune Disord Drug Targets. 2018;18(6):555-564. doi: 10.2174/1871530318666180611095622.
10
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.甲状腺癌:ESMO 诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 Dec 1;30(12):1856-1883. doi: 10.1093/annonc/mdz400.

引用本文的文献

1
Aggressive Thyroid Carcinomas Clinical and Molecular Features: A Systematic Review.侵袭性甲状腺癌的临床和分子特征:一项系统评价
Int J Mol Sci. 2025 Jun 10;26(12):5535. doi: 10.3390/ijms26125535.
2
Exploring the role of immunotherapy in the management of follicular cell-derived thyroid cancer.探索免疫疗法在滤泡细胞源性甲状腺癌治疗中的作用。
Immunotherapy. 2025 Jan;17(1):47-55. doi: 10.1080/1750743X.2025.2455922. Epub 2025 Feb 3.
3
SATB2 is an Emergent Biomarker of Anaplastic Thyroid Carcinoma: A Series with Comprehensive Biomarker and Molecular Studies.

本文引用的文献

1
Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.同一原发切除标本中并存分化型和间变甲状腺癌:连续 13 例两部分的免疫表型和遗传学比较及文献复习。
Virchows Arch. 2021 Feb;478(2):265-281. doi: 10.1007/s00428-020-02891-9. Epub 2020 Jul 18.
2
Squamous cell carcinoma of thyroid: a unique type of cancer in World Health Organization Classification.甲状腺鳞状细胞癌:世界卫生组织分类中的一种独特癌症类型。
Endocr Relat Cancer. 2020 Jun;27(6):R177-R192. doi: 10.1530/ERC-20-0045.
3
SATB2是间变性甲状腺癌的一种新兴生物标志物:一项综合生物标志物和分子研究系列。
Endocr Pathol. 2024 Dec;35(4):432-441. doi: 10.1007/s12022-024-09833-0. Epub 2024 Nov 5.
4
Benzyl isothiocyanate suppresses development of thyroid carcinoma by regulating both autophagy and apoptosis pathway.异硫氰酸苄酯通过调节自噬和凋亡途径来抑制甲状腺癌的发展。
iScience. 2024 Aug 23;27(10):110796. doi: 10.1016/j.isci.2024.110796. eCollection 2024 Oct 18.
5
Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis.从免疫治疗角度看甲状腺癌的新见解:文献计量分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2403170. doi: 10.1080/21645515.2024.2403170. Epub 2024 Sep 18.
6
New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma.探讨细胞外基质的作用机制及其在间变性甲状腺癌治疗中的潜在价值。
Sci Rep. 2024 Sep 9;14(1):20977. doi: 10.1038/s41598-024-72020-y.
7
A study on the safety and efficacy of endoscopic thyroidectomy via axillary approach for the treatment of thyroid cancer.经腋路内镜甲状腺切除术治疗甲状腺癌的安全性和有效性研究。
Medicine (Baltimore). 2024 Jun 21;103(25):e38507. doi: 10.1097/MD.0000000000038507.
8
Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.下一代测序鉴定出 RET 变异与甲状腺乳头状癌的淋巴结转移和免疫微环境有关。
BMC Endocr Disord. 2024 May 11;24(1):68. doi: 10.1186/s12902-024-01586-5.
9
Update on current diagnosis and management of anaplastic thyroid carcinoma.间变性甲状腺癌的当前诊断与管理进展
World J Clin Oncol. 2023 Dec 24;14(12):570-583. doi: 10.5306/wjco.v14.i12.570.
10
SPRY4 as a Potential Mediator of the Anti-Tumoral Role of Macrophages in Anaplastic Thyroid Cancer Cells.SPRY4作为巨噬细胞在间变性甲状腺癌细胞中抗肿瘤作用的潜在介导因子。
Cancers (Basel). 2023 Sep 1;15(17):4387. doi: 10.3390/cancers15174387.
Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations.
美国甲状腺癌发病率趋势:与专业指南建议变化的关联。
Thyroid. 2020 Aug;30(8):1132-1140. doi: 10.1089/thy.2019.0415. Epub 2020 Apr 3.
4
Intractable disseminated maculopapular eruption in a patient with granulocyte macrophage colony-stimulating factor-producing anaplastic thyroid carcinoma.粒细胞巨噬细胞集落刺激因子分泌型间变性甲状腺癌患者出现难治性播散性斑丘疹。
J Dermatol. 2019 Nov;46(11):e432-e433. doi: 10.1111/1346-8138.14950. Epub 2019 Jun 10.
5
Treatment Outcomes in Anaplastic Thyroid Cancer.间变性甲状腺癌的治疗结果
J Thyroid Res. 2019 May 23;2019:8218949. doi: 10.1155/2019/8218949. eCollection 2019.
6
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.整合分析与侵袭性甲状腺癌进展相关的基因组和转录组特征。
Nat Commun. 2019 Jun 24;10(1):2764. doi: 10.1038/s41467-019-10680-5.
7
Osteoclastic variant of anaplastic thyroid carcinoma: A case report of rare entity.间变性甲状腺癌的破骨细胞样变体:一例罕见病例报告
J Cancer Res Ther. 2019 Jul-Sep;15(3):704-707. doi: 10.4103/jcrt.JCRT_355_16.
8
Changing trends of incidence and prognosis of thyroid carcinoma.甲状腺癌发病率及预后的变化趋势
Nuklearmedizin. 2019 Mar;58(2):86-92. doi: 10.1055/a-0859-7454. Epub 2019 Mar 27.
9
An Update of the Appropriate Treatment Strategies in Anaplastic Thyroid Cancer: A Population-Based Study of 735 Patients.间变性甲状腺癌合理治疗策略的最新进展:一项基于735例患者的人群研究
Int J Endocrinol. 2019 Feb 19;2019:8428547. doi: 10.1155/2019/8428547. eCollection 2019.
10
Diagnosis and Management of Anaplastic Thyroid Cancer.间变性甲状腺癌的诊断与治疗。
Endocrinol Metab Clin North Am. 2019 Mar;48(1):269-284. doi: 10.1016/j.ecl.2018.10.010.